PrimaPharm successfully completes latest FDA cGMP inspection

June 18, 2013 – Today PrimaPharm has announced the US Food and Drug Administration (FDA) has completed its most recent inspection of the company’s manufacturing facility.  The entire facility and the quality systems used for the manufacture and release of drug products were subject to a detailed compliance inspection.  The inspection found the facility to be compliant with the principles and guidelines of current Good Manufacturing Practices (cGMPs).

On June 18, 2013, posted in: News by
Comments are closed.

You must be logged in to post a comment.